A2 Biotherapeutics (Series C)
Funding Details
- Awarder
- Inbox
- Date Award
- May 19, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $80,000,000
Company Info
- Company Description
- A2 Biotherapeutics is a clinical-stage biotech company developing first-in-class logic-gated cell therapies to address the high unmet need in cancers. A2 Bio invented the proprietary Tmod™ cell therapy platform to tackle the fundamental challenge in cancer treatment - the ability of cancer medicines to distinguish between tumor and normal cells.
- Market
- Cancer treatment
- Location
- Agoura Hills, California, USA
- Coinvestors
- The Column Group, Samsara BioCapital